State legislators aren’t proposing to “cut” care – they’re asking the health industry to stop treating patients like blank checks. It’s time for hospitals and other health industry ...

Gaps in communication, follow-up and medication management continue to put patients at risk after they leave the hospital. To strengthen discharge processes and ensure safer transitions of care ...

A large portion of these resources go towards care that is misaligned with patients' wishes or unwanted due to a lack of communication and planning about patients' end-of-life care preferences.

Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...

The continued success of abelacimab throughout the AZALEA-TIMI 71 trials helps draw the drug closer to FDA approval, stated ...

LAS said it had developed an action plan to improve care for patients with sickle cell disease, including more detailed training for all frontline clinicians and improving the use of pain relief.

“We are committed to providing the highest quality care and the safest environment for all patients, and reinforce all safeguards we have put in place,” the statement said. The hospital may ...

Findings of a research project carried out by the Sickle Cell Society into sickle cell patients’ experiences of ambulance care and 999 and 111 calls in London, revealed that many patients had ...

Boone Health Spokesperson Christian Basi said new providers in rural areas can accept 1,500 to 1,800 patients. A previous version of this story inaccurately described this patient minimum.

NHS Trust and carried out by the Sickle Cell Society – into sickle cell patients’ experiences of ambulance care and 999 and 111 calls in London revealed that many patients had negative ...

And that we have identified stakeholders through both care systems that ensure that the handoff is as smooth as possible and that really importantly the patient and their family feel supported ...

Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to ...